Clinical trial
Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder
NCT00034580 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00034580 |
|---|---|
| Title | Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder |
| Official title | Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder, Manic or Mixed |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | olanzapine, risperidone |
| Enrollment | 326 |
| Start date | Aug 1, 2001 |
| Completion | Aug 1, 2002 |
| First posted | May 1, 2002 |
| Last update posted | Jul 19, 2006 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: